Search by Drug Name or NDC

NDC 70934-0125-96 Bupropion Hydrochloride 150 mg/1 Details

Bupropion Hydrochloride 150 mg/1

Bupropion Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is BUPROPION HYDROCHLORIDE.

MedlinePlus Drug Summary

Bupropion (Aplenzin, Wellbutrin, Wellbutrin SR, Wellbutrin XL) is used to treat depression. Bupropion (Aplenzin, Wellbutrin XL) is also used to treat seasonal affective disorder (SAD; episodes of depression that occur at the same time each year [usually in the fall and winter but rarely may occur in the spring or summer months]). Bupropion (Zyban) is used to help people stop smoking. Bupropion is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain.

Related Packages: 70934-0125-96
Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Bupropion

Product Information

NDC	70934-0125
Product ID	70934-125_e39d890c-967f-3e2c-e053-2a95a90aa3f3
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Bupropion Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Bupropion Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	150
Active Ingredient Units	mg/1
Substance Name	BUPROPION HYDROCHLORIDE
Labeler Name	Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Pharmaceutical Class	Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090693
Listing Certified Through	n/a

Package

NDC 70934-0125-96 (70934012596)

Pricing Information	N/A
NDC Package Code	70934-125-96
Billing NDC	70934012596
Package	180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-125-96)
Marketing Start Date	2022-07-07
NDC Exclude Flag	N